Robert Hamilton Pierce - 15 Feb 2022 Form 4/A - Amendment Insider Report for Sensei Biotherapeutics, Inc. (SNSE)

Role
Chief R&D Officer
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Issuer symbol
SNSE
Transactions as of
15 Feb 2022
Net transactions value
$0
Form type
4/A - Amendment
Filing time
01 Sep 2022, 16:57:33 UTC
Date Of Original Report
17 Feb 2022
Previous filing
12 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SNSE Common Stock 94,463 15 Feb 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 17, 2022, the reporting person filed a Form 4 which inadvertently reported an incorrect number of shares owned. This amendment is filed solely to correct the number of shares owned.